𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance

✍ Scribed by Mulshine, James L.; Johnson, Bruce E.; Gazdar, Adi F.; Shaw, Gail L.; Kramer, Barnett S.; Mitsudomi, Tetsuya; Minna, John D.; Pass, Harvey; Phelps, Ruby; Ghosh, Bimal; Ilona Linnoila, R.; Ihde, Daniel C.

Book ID
122465742
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
776 KB
Volume
10
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Apoptosis in non-small cell lung cancer
Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis
✍ G. Stammler; M. Volm πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 382 KB

The percentage of apoptotic cells among the tumor cells (apoptotic index) was determined in a series of 178 non-small cell lung carcinomas with a long term clinical follow-up by a terminal desoxynucleotidyl transferase mediated dUTP nick end labelling technique. In survival analysis, we found no sta

Targeting BCL-2 family proteins to overc
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer
✍ Emmanuelle Wesarg; Sandra Hoffarth; Rainer Wiewrodt; Monika KrΓΆll; Stefan Bieste πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 422 KB

## Abstract Cytotoxic chemotherapies are standard of care for patients suffering from advanced non‐small cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and long‐term survival is rarely observed. Clinically applied anticancer drugs exert at least some of the